179 related articles for article (PubMed ID: 15723619)
1. Novel biological agents for the treatment of hormone-refractory prostate cancer (HRPC).
Papatsoris AG; Karamouzis MV; Papavassiliou AG
Curr Med Chem; 2005; 12(3):277-96. PubMed ID: 15723619
[TBL] [Abstract][Full Text] [Related]
2. Treatment options in hormone-refractory prostate cancer: current and future approaches.
Harris KA; Reese DM
Drugs; 2001; 61(15):2177-92. PubMed ID: 11772129
[TBL] [Abstract][Full Text] [Related]
3. Drug development in prostate cancer.
Ripple GH; Wilding G
Semin Oncol; 1999 Apr; 26(2):217-26. PubMed ID: 10597732
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapeutic approaches for hormone-refractory prostate cancer.
Stavridi F; Karapanagiotou EM; Syrigos KN
Cancer Treat Rev; 2010 Apr; 36(2):122-30. PubMed ID: 20106600
[TBL] [Abstract][Full Text] [Related]
5. Newer therapies in advanced prostate cancer.
Hegeman RB; Liu G; Wilding G; McNeel DG
Clin Prostate Cancer; 2004 Dec; 3(3):150-6. PubMed ID: 15636681
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for hormone-refractory prostate cancer.
Shelley M; Harrison C; Coles B; Staffurth J; Wilt TJ; Mason MD
Cochrane Database Syst Rev; 2006 Oct; (4):CD005247. PubMed ID: 17054249
[TBL] [Abstract][Full Text] [Related]
7. Hormone-refractory prostate cancer: where are we going?
Di Lorenzo G; Autorino R; Figg WD; De Placido S
Drugs; 2007; 67(8):1109-24. PubMed ID: 17521214
[TBL] [Abstract][Full Text] [Related]
8. Novel therapeutic approaches to advanced prostate cancer.
Armstrong AJ; Carducci MA
Clin Adv Hematol Oncol; 2005 Apr; 3(4):271-82. PubMed ID: 16167000
[TBL] [Abstract][Full Text] [Related]
9. State-of-the-art treatment of metastatic hormone-refractory prostate cancer.
Goodin S; Rao KV; DiPaola RS
Oncologist; 2002; 7(4):360-70. PubMed ID: 12185298
[TBL] [Abstract][Full Text] [Related]
10. Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer.
Sato M; Johnson M; Zhang L; Gambhir SS; Carey M; Wu L
Clin Cancer Res; 2005 May; 11(10):3743-9. PubMed ID: 15897571
[TBL] [Abstract][Full Text] [Related]
11. [Taxanes in the chemotherapy of hormone-refractory prostate carcinoma].
Johannsen M; Wilke K; Schnorr D; Loening SA
Urologe A; 2004 Feb; 43(2):160-7. PubMed ID: 14991117
[TBL] [Abstract][Full Text] [Related]
12. Management of the spectrum of hormone refractory prostate cancer.
Clarke NW
Eur Urol; 2006 Sep; 50(3):428-38; discussion 438-9. PubMed ID: 16797118
[TBL] [Abstract][Full Text] [Related]
13. Role of chemotherapy in hormone-refractory prostate cancer. Old issues, recent advances and new perspectives.
Autorino R; Di Lorenzo G; Damiano R; De Placido S; D'Armiento M
Urol Int; 2003; 70(1):1-14. PubMed ID: 12566808
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth.
Mashima T; Okabe S; Seimiya H
Mol Pharmacol; 2010 Nov; 78(5):846-54. PubMed ID: 20709811
[TBL] [Abstract][Full Text] [Related]
15. Hormone refractory prostate cancer (HRPC): present and future approaches of therapy.
Di Lorenzo G; De Placido S
Int J Immunopathol Pharmacol; 2006; 19(1):11-34. PubMed ID: 16569343
[TBL] [Abstract][Full Text] [Related]
16. Designed modulation of sex steroid signaling inhibits telomerase activity and proliferation of human prostate cancer cells.
Verma V; Sharma V; Singh V; Sharma S; Bishnoi AK; Chandra V; Maikhuri JP; Dwivedi A; Kumar A; Gupta G
Toxicol Appl Pharmacol; 2014 Oct; 280(2):323-34. PubMed ID: 25123791
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic options for hormone-refractory prostate cancer in 2007.
Hadaschik BA; Gleave ME
Urol Oncol; 2007; 25(5):413-9. PubMed ID: 17826663
[TBL] [Abstract][Full Text] [Related]
18. Novel molecular targets for prostate cancer therapy.
Kamradt JM; Pienta KJ
Semin Oncol; 1999 Apr; 26(2):234-43. PubMed ID: 10597734
[TBL] [Abstract][Full Text] [Related]
19. New strategies for the medical treatment of prostate cancer.
Isaacs JT
BJU Int; 2005 Dec; 96 Suppl 2():35-40. PubMed ID: 16359437
[TBL] [Abstract][Full Text] [Related]
20. Novel clinical trials in androgen-independent prostate cancer.
Gulley J; Dahut W
Clin Prostate Cancer; 2002 Jun; 1(1):51-7. PubMed ID: 15046713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
